Apellis Pharmaceuticals Stock Forecast - Relative Strength Index

APLS Stock  USD 25.98  0.86  3.42%   
Apellis Stock Forecast is based on your current time horizon.
At this time the rsi of Apellis Pharmaceuticals' share price is below 20 . This suggests that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards.

Momentum 0

 Sell Peaked

 
Oversold
 
Overbought
The successful prediction of Apellis Pharmaceuticals' future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Apellis Pharmaceuticals and does not consider all of the tangible or intangible factors available from Apellis Pharmaceuticals' fundamental data. We analyze noise-free headlines and recent hype associated with Apellis Pharmaceuticals, which may create opportunities for some arbitrage if properly timed. Below are the key fundamental drivers impacting Apellis Pharmaceuticals' stock price prediction:
EPS Estimate Next Quarter
(0.31)
EPS Estimate Current Year
0.2755
EPS Estimate Next Year
(1.16)
Wall Street Target Price
35
EPS Estimate Current Quarter
0.9418
Using Apellis Pharmaceuticals hype-based prediction, you can estimate the value of Apellis Pharmaceuticals from the perspective of Apellis Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Apellis Pharmaceuticals using Apellis Pharmaceuticals' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Apellis using crowd psychology based on the activity and movement of Apellis Pharmaceuticals' stock price.

Apellis Pharmaceuticals Short Interest

An investor who is long Apellis Pharmaceuticals may also wish to track short interest. As short interest increases, investors should be becoming more worried about Apellis Pharmaceuticals and may potentially protect profits, hedge Apellis Pharmaceuticals with its derivative instruments, or be ready for some potential downside.
200 Day MA
21.908
Short Percent
0.1794
Short Ratio
7.8
Shares Short Prior Month
16.1 M
50 Day MA
23.1593

Apellis Pharmaceuticals Hype to Price Pattern

Investor biases related to Apellis Pharmaceuticals' public news can be used to forecast risks associated with an investment in Apellis. The trend in average sentiment can be used to explain how an investor holding Apellis can time the market purely based on public headlines and social activities around Apellis Pharmaceuticals. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Apellis Pharmaceuticals' market sentiment to its price can help taders to make decisions based on the overall investors consensus about Apellis Pharmaceuticals.

Apellis Pharmaceuticals Implied Volatility

    
  0.7  
Apellis Pharmaceuticals' implied volatility exposes the market's sentiment of Apellis Pharmaceuticals stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Apellis Pharmaceuticals' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Apellis Pharmaceuticals stock will not fluctuate a lot when Apellis Pharmaceuticals' options are near their expiration.

Apellis Pharmaceuticals after-hype prediction price

    
  USD 25.41  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Apellis Pharmaceuticals to cross-verify your projections.
For more information on how to buy Apellis Stock please use our How to Invest in Apellis Pharmaceuticals guide.At this time, Apellis Pharmaceuticals' Inventory Turnover is comparatively stable compared to the past year. Fixed Asset Turnover is likely to gain to 38.79 in 2026, whereas Payables Turnover is likely to drop 3.23 in 2026. . Common Stock Shares Outstanding is likely to gain to about 149.6 M in 2026, despite the fact that Net Loss is likely to grow to (557.6 M).

Open Interest Against 2026-02-20 Apellis Option Contracts

Although open interest is a measure utilized in the options markets, it could be used to forecast Apellis Pharmaceuticals' spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Apellis Pharmaceuticals' options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Apellis Pharmaceuticals stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Apellis Pharmaceuticals' open interest, investors have to compare it to Apellis Pharmaceuticals' spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Apellis Pharmaceuticals is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Apellis. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.

Apellis Pharmaceuticals Additional Predictive Modules

Most predictive techniques to examine Apellis price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Apellis using various technical indicators. When you analyze Apellis charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
Apellis Pharmaceuticals has current Relative Strength Index of 0.
Check Apellis Pharmaceuticals VolatilityBacktest Apellis PharmaceuticalsInformation Ratio  

Apellis Pharmaceuticals Trading Date Momentum

On January 02 2026 Apellis Pharmaceuticals was traded for  25.98  at the closing time. The top price for the day was 25.98  and the lowest listed price was  25.02 . There was no trading activity during the period 0.0. Lack of trading volume on January 2, 2026 did not affect price variability. The overall trading delta against the current closing price is 3.31% .
Compare Apellis Pharmaceuticals to competition

Other Forecasting Options for Apellis Pharmaceuticals

For every potential investor in Apellis, whether a beginner or expert, Apellis Pharmaceuticals' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Apellis Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Apellis. Basic forecasting techniques help filter out the noise by identifying Apellis Pharmaceuticals' price trends.

Apellis Pharmaceuticals Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Apellis Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Apellis Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Apellis Pharmaceuticals by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Apellis Pharmaceuticals Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Apellis Pharmaceuticals' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Apellis Pharmaceuticals' current price.

Apellis Pharmaceuticals Market Strength Events

Market strength indicators help investors to evaluate how Apellis Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Apellis Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Apellis Pharmaceuticals stock market strength indicators, traders can identify Apellis Pharmaceuticals entry and exit signals to maximize returns.

Apellis Pharmaceuticals Risk Indicators

The analysis of Apellis Pharmaceuticals' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Apellis Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting apellis stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Apellis Stock Analysis

When running Apellis Pharmaceuticals' price analysis, check to measure Apellis Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Apellis Pharmaceuticals is operating at the current time. Most of Apellis Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Apellis Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Apellis Pharmaceuticals' price. Additionally, you may evaluate how the addition of Apellis Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.